Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
How have research questions and methods used in clinical trials published in Clinical Rehabilitation changed over the last 30 years?
Pandemic H1N1 Vaccination and Incidence of Acute Disseminated Encephalomyelitis in Manitoba.
Glucocorticoid receptor haplotypes conferring increased sensitivity (BclI and N363S) are associated with faster progression of multiple sclerosis.
The development of an observational screening tool to assess safe, effective and appropriate walking aid use in people with multiple sclerosis.
Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses.
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
Inflammation Induces TDP-43 Mislocalization and Aggregation.
White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.
Is my MS patient failing treatment?
Salt intake in multiple sclerosis: friend or foe?
The role of the wnt canonical signaling in neurodegenerative diseases.
Data quality evaluation for observational multiple sclerosis registries.
Intravenous Methylprednisolone-Induced Nocturnal Sinus Bradycardia in a Multiple Sclerosis Patient.
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes.
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
[Acute transverse myelitis in a traveler].
Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions.
Cortical gray and subcortical white matter associations in Parkinson's disease.
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
EP23.01: Postive postnatal outcome in pregnancy with neuromyelitis optica.
Pages
« first
‹ previous
…
782
783
784
785
786
787
788
789
790
…
next ›
last »